Is HRT Safe? What the Research Actually Says in 2026
Medically reviewed by Dr. Mia Chorney, DNP, FNP-BC, MSCP — Cofounder & Chief Medical Officer, Amsara Health
For more than twenty years, one question has dominated every menopause conversation: is hormone replacement therapy safe? The short answer, according to the current evidence: for most healthy women who begin within ten years of menopause or before age 60, the benefits of hormone therapy outweigh the risks. Here is how we got from two decades of fear to that answer — and what it means for you.
What happened in 2002 — and why it still matters
In 2002, the Women’s Health Initiative (WHI) — the largest hormone therapy trial ever run — was stopped early, and the headlines that followed changed medicine overnight. What the headlines missed: the average participant was 63 years old, more than a decade past menopause, and the trial tested one specific formulation at one dose. Those results were generalized to every woman, at every age, on every therapy.
The consequences were measurable. Hormone therapy use among menopausal women fell from roughly 27% in 1999 to under 5% — and it has stayed there, even as the evidence changed. A generation of women sweated through sleepless nights because of a study that was never about them.
What does the research actually say now?
In 2017, the WHI investigators themselves published an 18-year follow-up of more than 27,000 participants in JAMA: hormone therapy was associated with no increase in all-cause, cardiovascular, or cancer mortality. In 2022, The Menopause Society’s hormone therapy position statement concluded that for symptomatic women under 60 or within 10 years of menopause onset, benefits outweigh risks — for hot flashes, night sweats, bone protection, and genitourinary symptoms.
Timing is the through-line. Started early, hormone therapy behaves very differently than it does when started late — which is exactly the distinction the 2002 headlines erased.
What did the FDA change in 2025?
In November 2025, the FDA announced it would remove the black-box warnings from estrogen-containing hormone therapy products — the strongest warning labels in medicine, in place since the WHI era. Labels are being rewritten with age-specific guidance noting that women may see long-term health benefits when therapy begins within ten years of menopause onset. It is the clearest official acknowledgment yet that the pendulum swung too far.
Who is hormone therapy right for?
Hormone therapy is not one decision — it is a series of individualized ones: which hormones, which route, what dose, and for how long. It tends to be a strong option for healthy women with disruptive symptoms who are within the timing window. It requires more caution — and sometimes different tools — for women with a history of breast cancer, blood clots, stroke, or certain cardiovascular conditions.
That judgment call is why credentials matter. At Amsara Health, hormone therapy decisions are led by Menopause Society Certified Practitioners and board-certified physicians who specialize in midlife health — after comprehensive labs, not before them.
How do I find out if it’s right for me?
Start with data. A comprehensive hormone and metabolic panel establishes your baseline; an unhurried visit maps your symptoms and history against it; and your plan — hormone therapy or not — is built from both. That is the entire model behind our care for women, and it starts with a single visit.
This article is for education only and is not medical advice. Talk with a qualified clinician about your individual health before starting or stopping any therapy.
Wondering what HRT could mean for you?
Unhurried appointments, advanced diagnostics, and a plan built for you.
Already a patient? Visit your Amsara Patient Portal →
